Introduction (Article introduction authored by INCA Editorial Team) Sepsis is a life-threatening condition that frequently occurs in ICU patients with
INCACARE
Welcome To
Incacare Live
Incacare Live is an initiative by Concord Biotech to keep you updated with recent advances in critical care. The website shares information regarding incidences of opportunistic fungal infections in patients.
Concord Biotech is a vertically integrated, R&D driven biotechnological powerhouse manufacturing API’s and Finished formulations, offers products across diversified therapeutic segments.
Blog
INTENSIVE CARE UPDATES
Introduction (Article introduction authored by INCA Editorial Team) Sepsis, a life-threatening condition caused by a dysregulated immune response to infection,
Acinetobacter baumannii Complex Infections: New Treatment Options in the Antibiotic Pipeline
Introduction (Article introduction authored by INCA Editorial Team) Acinetobacter baumannii complex (ABC), particularly its carbapenem-resistant strains (CRAB), presents a significant
The Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection
Introduction Intra-abdominal infections (IAIs) are a significant, often life-threatening condition affecting millions of patients annually, with treatment responsibility typically distributed
Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
Introduction In recent years, invasive fungal infections have emerged as a significant public health threat, particularly among immunocompromised individuals such
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Introduction Invasive fungal diseases (IFD) pose significant morbidity and mortality risks, particularly among immunocompromised patients, but they can also affect